Similarly, the DOPPS study showed a trend towards an increased infection-related mortality in prevalent HD patients treated with > 300 mg of IV iron [ 14 ].
← all excerpts
Safety concerns about intravenous iron therapy in patients with chronic kidney disease.
1
—
—